Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Entera Bio (ENTX) Other Operating Expenses (2021 - 2023)

Entera Bio has reported Other Operating Expenses over the past 3 years, most recently at $10000.0 for Q4 2023.

  • For the quarter ending Q4 2023, Other Operating Expenses fell 44.44% year-over-year to $10000.0, compared with a TTM value of $10000.0 through Sep 2024, down 82.46%, and an annual FY2023 reading of $49000.0, down 3.92% over the prior year.
  • Other Operating Expenses came in at $10000.0 for Q4 2023, down from $12000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $18000.0 in Q4 2022 to a low of $6000.0 in Q3 2022.
  • Median Other Operating Expenses over the past 3 years was $12000.0 (2022), compared with a mean of $12083.3.
  • The sharpest move saw Other Operating Expenses crashed 45.45% in 2022, then surged 100.0% in 2023.
  • Over 3 years, Other Operating Expenses stood at $14000.0 in 2021, then grew by 28.57% to $18000.0 in 2022, then tumbled by 44.44% to $10000.0 in 2023.
  • Per Business Quant, the three most recent readings for ENTX's Other Operating Expenses are $10000.0 (Q4 2023), $12000.0 (Q3 2023), and $14000.0 (Q2 2023).